A detailed history of Tom Russo (Gardner Russo & Quinn LLC) transactions in Abb Vie Inc. stock. As of the latest transaction made, Gardner Russo & Quinn LLC holds 12,510 shares of ABBV stock, worth $2.21 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
12,510
Previous 12,510 -0.0%
Holding current value
$2.21 Million
Previous $2.15 Million 15.15%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$137.6 - $154.97 $10,044 - $11,312
-73 Reduced 0.58%
12,510 $1.94 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $1,068 - $1,237
-8 Reduced 0.06%
12,583 $1.88 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $2,517 - $3,133
-19 Reduced 0.15%
12,591 $1.7 Million
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $41,286 - $52,488
-300 Reduced 2.32%
12,610 $1.93 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $31,920 - $36,234
300 Added 2.38%
12,910 $1.39 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $1,374 - $1,613
16 Added 0.13%
12,610 $1.11 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $6,163 - $8,247
84 Added 0.67%
12,594 $1.24 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $19,350 - $29,337
-300 Reduced 2.34%
12,510 $953,000
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $14,426 - $18,050
-200 Reduced 1.54%
12,810 $1.13 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $73,745 - $86,795
-956 Reduced 6.85%
13,010 $1.05 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $23,881 - $28,257
266 Added 1.94%
13,966 $1.29 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $36,804 - $49,284
-400 Reduced 2.84%
13,700 $1.3 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $331,372 - $363,377
-3,700 Reduced 20.79%
14,100 $1.36 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $111,759 - $142,752
1,600 Added 9.88%
17,800 $1.58 Million
Q2 2017

Aug 14, 2017

BUY
N/A
16,200
16,200 $1.18 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track Tom Russo's Portfolio

Track Tom Russo Portfolio

Follow Tom Russo (Gardner Russo & Quinn LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gardner Russo & Quinn LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gardner Russo & Quinn LLC and Tom Russo with notifications on news.